Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Objective</h3><p>To investigate the plasma fibrinogen gamma‐chain concentration in preeclampsia patients and explore its value in preeclampsia prediction and auxiliary diagnosis.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Follow‐up of pregnant women who regularly attended perinatal care at two hospitals in China was performed, and clinical data and plasma samples were collected at each examination until delivery. The gamma‐chain concentration was detected by Western blotting, and Quantity One Software was used for gamma‐chain grayscale value measurements.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Forty‐two patients with preeclampsia and 42 control patients completed the follow‐up. In the control group, the gamma‐chain concentration at 32 weeks of gestation was higher than that at 20 weeks of gestation, but the difference was not statistically significant (<i>p</i> > 0.05). In the experimental group, the gamma‐chain concentration at preeclampsia diagnosis was significantly higher than that at 20 weeks of gestation (<i>p</i> < 0.05). Compared with the control group, the gamma‐chain concentration was higher at 20 weeks of gestation in the experimental group, but the difference was not statistically significant. However, at 32 weeks of gestation and at the time of diagnosis, the gamma‐chain concentration in the experimental group was significantly higher than that in the control group (<i>p</i> < 0.05). At 32 weeks of gestation and at the time of diagnosis, the AUCs from ROC curve analysis of plasma fibrinogen gamma‐chain concentrations were 0.64 and 0.71, respectively. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>Plasma fibrinogen synthesis and degradation were disrupted in preeclampsia patients before and after diagnosis, and gamma‐chain concentration was significantly increased. Plasma fibrinogen gamma chain may be of some value in preeclampsia prediction and auxiliary diagnosis.</p></section>

Changes of Plasma and Placental Tissue Factor Pathway Inhibitor-2 in Women with Preeclampsia and Normal Pregnancy

Alternations of maternal and cord plasma hemostasis in preeclampsia before and after delivery.

Placental Imbalance of Th1‐ and Th2‐type Cytokines in Preeclampsia

Tissue Factor Pathway Inhibitors as Potential Targets for Understanding the Pathophysiology of Preeclampsia

Alterations of maternal serum and placental follistatin-like 3 and myostatin in pre-eclampsia.

Increased Expression of Fatty Acid Binding Protein 4 in Preeclamptic Placenta and Its Relevance to Preeclampsia.

Serum and Placental Interleukin-18 Are Elevated in Preeclampsia

Declined placental PLAC1 expression is involved in preeclampsia.

Alterations in Serum Adipocyte Fatty Acid Binding Protein and Retinol Binding Protein-4 in Normal Pregnancy and Preeclampsia.

Imbalance of Serum T Helper 1- and 2-Type Cytokines in Preeclampsia and Gestational Hypertension

Association of a Reduction of G-protein Coupled Receptor 30 Expression and the Pathogenesis of Preeclampsia

Placental Proteome Alterations in Women with Intrahepatic Cholestasis of Pregnancy.

Maternal alternations of haemostasis and thrombosis in preeclampsia

Changes of serum cardiotropin I and cystatin C in preeclampsia and significance thereof

Involvement of Follistatin-Like 3 in Preeclampsia

[Expression of Fas and FasL in Serum and Placenta of Preeclamptic Pregnancy and Its Significance].

[Relationship Between Serum and Placental Interleukin-18 Levels and Preeclampsia].

Changes and significance of plasma fibrinogen gamma‐chain concentration in preeclampsia patients

Blood coagulation parameters and platelet indices: changes in normal and preeclamptic pregnancies and predictive values for preeclampsia

Fibrinolytic Changes in Women with Preeclampsia

Elevated Serum Levels of Interleukin-15 and Interleukin-16 in Preeclampsia.